API
Click for more information
0.00% $1.53 australian pharmaceutical industries limited

Ann: API Board rejects indicative proposal from Wesfarmers, page-18

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
TRADE NOW
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
  1. apoel
    1,298 Posts.
    lightbulb Created with Sketch. 68
    clock Created with Sketch.
    13/09/21
    10:58
    Post #: 56014791
    The way that WES is behaving doesn't make sense.
    I assume they have identified Pharmacy as a strategic segment to be in.
    Once they have done that, to try to penny-pinch makes no sense, especially when API is so small compared to them (1% of their market cap)
    API Price at posting: $1.33 Sentiment: None Disclosure: Not Held
    Likes Created with Sketch. 2  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS Drilling at May Queen intersects altered porphyritic rocks and copper sulphides, supporting a large-scale copper-gold system
right-arrow Created with Sketch.
NEWS Drilling kicks off at Goldsworthy East—30 holes planned to unlock major westward potential
right-arrow Created with Sketch.
RCE Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger
right-arrow Created with Sketch.
NEWS Shallow high-grade gold hits at Star of Mangaroon and Popeye—see the latest drill results and what’s next
right-arrow Created with Sketch.
NEWS High-grade antimony mineralization confirmed at Ricciardo with potential 1km strike length
right-arrow Created with Sketch.
NEWS Eagles Nest drilling confirms high-grade gold with shallow mineralisation expanding, delivering multiple strong intersections
right-arrow Created with Sketch.
watchlist Created with Sketch. Add API (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.